Trial Search Results

18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation

The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using 18F-FSPG PET/MRI.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: GE Healthcare

Stanford Investigator(s):


  • Drug: 18F-FSPG


Phase 2


Inclusion Criteria:

   - Patient is ≥ 18 years old at the time of the scan

   - Patient with known or suspected cardiac sarcoidosis.

   - Patient is capable of complying with study procedures

   - Patient can remain still for duration of imaging procedure

Exclusion Criteria:

   - Patient is pregnant or nursing

   - Metallic implants (contraindicated for MRI)

   - History of renal insufficiency (only for MRI contrast administration)

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Andrea Otte, DPT